KPV is a C-terminal tripeptide of alpha-MSH studied for its anti-inflammatory and antimicrobial properties in research settings.
KPV is a tripeptide (Lys-Pro-Val) representing the C-terminal sequence of alpha-melanocyte stimulating hormone. This short peptide retains anti-inflammatory properties without melanogenic effects. Researchers study KPV for its immunomodulatory and antimicrobial activities in laboratory models.
Scientific research on KPV examines its anti-inflammatory and antimicrobial mechanisms. Studies focus on its effects on inflammatory cytokine reduction, NF-κB pathway inhibition, gut barrier function, and antimicrobial activity. Researchers investigate its mechanisms involving melanocortin-independent anti-inflammatory signaling and potential therapeutic applications in experimental settings.
For laboratory research purposes only. Not for human consumption or clinical use. This product is intended solely for in-vitro research and educational applications.

Explore similar peptides and compounds that researchers often study together